Cargando…
Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action(1)
Attempts to develop a disease modifying intervention for Alzheimer’s disease (AD) through targeting amyloid β (Aβ) have so far been unsuccessful. There is, therefore, a need for novel therapeutics against alternative targets coupled with approaches which may be suitable for early and sustained use l...
Autores principales: | Hole, Katriona L., Williams, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990465/ https://www.ncbi.nlm.nih.gov/pubmed/33782649 http://dx.doi.org/10.3233/BPL-200098 |
Ejemplares similares
-
Immunotherapy for Alzheimer’s disease: hoops and hurdles
por: Lemere, Cynthia A
Publicado: (2013) -
Defining the critical hurdles in cancer immunotherapy
por: Fox, Bernard A, et al.
Publicado: (2011) -
Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
por: Hole, Katriona L., et al.
Publicado: (2021) -
Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy
por: Oxford, Alexandra E., et al.
Publicado: (2020) -
Hurdling and Hurtling Toward New Genetic Codes
por: Zhang, Fan, et al.
Publicado: (2020)